<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03027115</url>
  </required_header>
  <id_info>
    <org_study_id>MHUMC 2016.10.05</org_study_id>
    <nct_id>NCT03027115</nct_id>
  </id_info>
  <brief_title>Hernia Surgery Urinary Retention</brief_title>
  <official_title>Post-operative Urinary Retention: A Prospective Randomized Study Identifying Patients at Risk and Reducing the Incidence Using Tamsulosin Pretreatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Health University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Health University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigating whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist
      affects the likelihood of male patients developing post-operative urinary retention following
      hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study will be to investigate whether pre-operative treatment with a
      selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing
      post-operative urinary retention following hernia repair surgery. It is also of interest to
      determine whether or not a well-known urological screening tool, the IPSS, can identify
      patients at risk for urinary retention following elective laparoscopic or open hernia repair
      surgery. We will investigate if it is possible to pre-treat patients with a selective
      alpha1-adrenoceptor antagonist which we think can reduce the incidence of post-operative
      urinary retention and the associated adverse consequences, especially in those patients at
      higher risk.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2017</start_date>
  <completion_date type="Anticipated">January 27, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 13, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization to 1 of 2 possible arms, control and treatment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative urinary retention</measure>
    <time_frame>2 weeks</time_frame>
    <description>Incidence of post-operative urinary retention in patients undergoing hernia repair</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of IPSS</measure>
    <time_frame>2 weeks</time_frame>
    <description>the variance in the relationship between treatment arm and incidence of post-operative urinary retention in patients undergoing hernia repair that is attributable to International Prostate Symptom Score (IPSS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hernia</condition>
  <condition>Urinary Retention</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment with a selective alpha1-adrenoceptor antagonist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <description>Tamsulosin treatment for 7 days pre-operatively</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Flomax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  18 years of age

          -  Presenting with hernia requiring surgical intervention

        Exclusion Criteria:

          -  Intolerability of tamsulosin or related drugs

          -  Investigator discretion

          -  Unwillingness or inability to comply with protocol procedures and assessments
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vishu Danthuluri, M.D.</last_name>
    <phone>256.665-6214</phone>
    <email>vishwanathdanthuluri@memorialhealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrew Schwemmer, M.D.</last_name>
    <email>SchweAn2@memorialhealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Health University Medical Center</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vishu Danthuluri, M.D.</last_name>
      <phone>256-665-5214</phone>
      <email>vishwanathdanthuluri@memorialhealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Schwemmer, M.D.</last_name>
      <email>SchweAn2@memorialhealth.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2017</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share IPD.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

